oasys 8.8 kit 104 lenses
johnson & johnson s.e. d.o.o. oreškovićeva 6 h 10000 zagreb -
mekinist
novartis europharm limited - trametinib - melanoma - antineoplastična sredstva - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 i 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. Немелкоклеточный rak pluća (НМРЛ)trametinib u kombinaciji s dabrafenib indiciran za liječenje odraslih bolesnika s preliminarnim non-mali raka pluća stanice s Браф mutacija v600 daleko .
qaialdo
nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 i 5.
lenalidomide mylan
mylan ireland limited - lenalidomid - multipli mijelom - imunosupresivi - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).
copalia hct
novartis europharm limited - amlodipin, валсартан, hidroklorotiazid - hipertenzija - antagonisti angiotenzina ii u kombinaciji, agenti koji djeluju na ренин-ангиотензиновую sustav, antagonisti angiotenzina ii i antagonisti kalcija - liječenje esencijalne hipertenzije kao zamjena terapija u odraslih bolesnika čiji krvni tlak odgovarajuće kontroliran na kombinaciji amlodipin, valsartan i hidroklorotiazid (hct), uzeti kao tri pojedinačnih formulacije ili je dvojan-komponenta i pojedinačnih formulacija.
exforge
novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - hipertenzija - sredstva koja djeluju na sustav renin-angiotenzina - liječenje esencijalne hipertenzije. exforge indiciran kod pacijenata kod kojih je krvni pritisak nije dovoljno prati na amlodipin ili валсартан kao monoterapija.
tadalafil mylan
mylan pharmaceuticals limited - tadalafil - poremećaj erekcije - urologicals - liječenje erektilne disfunkcije kod odraslih muškaraca. da bi tadalafil bio učinkovit, potrebna je seksualna stimulacija. tadalafil mylan u se ne navodi za žene.
olynth ha 0,5 mg/ml sprej za nos, otopina
johnson & johnson s.e. d.o.o., oreškovićeva 6h, zagreb, hrvatska - ksilometazolinklorid - sprej za nos, otopina - 0,5 mg/ml - urbroj: jedan ml spreja za nos, otopine sadrži 0,5 mg ksilometazolinklorida; jedan potisak (70 µl) sadrži 0,035 mg ksilometazolinklorida
olynth ha 1 mg/ml sprej za nos, otopina
johnson & johnson s.e. d.o.o., oreškovićeva 6h, zagreb, hrvatska - ksilometazolinklorid - sprej za nos, otopina - 1 mg/ml - urbroj: jedan ml spreja za nos, otopine sadrži 1 mg ksilometazolinklorida; jedan potisak (140 µl) sadrži 0,140 mg ksilometazolinklorida
olytabs 200 mg/30 mg filmom obložene tablete
johnson & johnson s.e. d.o.o., oreškovićeva 6h, zagreb, hrvatska - ibuprofenum, pseudoephedrinum - filmom obložena tableta - 200 mg + 30 mg - urbroj: jedna filmom obložena tableta sadrži 200 mg ibuprofena i 30 mg pseudoefedrinklorida